A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin

Yuetiva Deming, Jian Xia, Yefei Cai, Jenny Lord, Peter Holmans, Sarah Bertelsen, David Holtzman, John C. Morris, Kelly Bales, Eve H. Pickering, John Kauwe, Alison Goate, Carlos Cruchaga

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Genome-wide association studies have associated clusterin (CLU) variants with Alzheimer's disease (AD). However, the role of CLU on AD pathogenesis is not totally understood. We used cerebrospinal fluid (CSF) and plasma CLU levels as endophenotypes for genetic studies to understand the role of CLU in AD. CSF, but not plasma, CLU levels were significantly associated with AD status and CSF tau/amyloid-beta ratio, and highly correlated with CSF apolipoprotein E (APOE) levels. Several loci showed almost genome-wide significant associations including LINC00917 (p = 3.98 × 10−7) and interleukin 6 (IL6, p = 9.94 × 10−6, in the entire data set and in the APOE ε4- individuals p = 7.40 × 10−8). Gene ontology analyses suggest that CSF CLU levels may be associated with wound healing and immune response which supports previous functional studies that demonstrated an association between CLU and IL6. CLU may play a role in AD by influencing immune system changes that have been observed in AD or by disrupting healing after neurodegeneration.

Original languageEnglish
Pages (from-to)208.e1-208.e9
JournalNeurobiology of Aging
Volume37
DOIs
StatePublished - Jan 1 2016

Keywords

  • APOE
  • Alzheimer's disease
  • Cerebrospinal fluid
  • Clusterin
  • Gene ontology
  • Immune response

Fingerprint

Dive into the research topics of 'A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin'. Together they form a unique fingerprint.

Cite this